Airborne viral contamination has been a major concern during the current COVID-19 pandemics as Coronavirus infection spreads mainly via air droplets, especially indoors. Besides, other respiratory viruses have a similar infection pattern.
It is therefore important to develop and validate robust air of air filters sanitization systems which may mitigate the risk of airborne infectivity.
Eurofins BioPharma Product Testing in Italy has developed a panel of tests to challenge claims of airborne virus reduction of infectivity in pilot air ducts in order to verify the effectiveness of sanitizing systems connected to air ducts and air filters.
Tests are performed following the prescriptions, as applicable, of technical norms related to efficacy testing of airborne microorganisms, such as ISO 15714: 2019. These tests are tailor-made to test viruses and different industrial flowrates and duct sizes.
Each test is performed only after a robust client’s suite setup and validation is carried out in order to make sure reliable data are issues. Such tests are applicable for example to UV-C systems, treated filters.
